therapeutic trial fatty acid supplementation cystic fibrosis seven child cystic fibrosis cf treated least one year intravenously administered soya oil emulsion improvement least one biochemical abnormality character disease appeared childrens clinical course remains benign course remarkably better child cf treated without intralipid auckland period though placebo effect cannot discounted postulated intravenous supplementation essential fatty acid cf may turn partially correct error metabolism prostaglandin present disease